These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20579888)

  • 1. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
    Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
    J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
    Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
    Borowski P; Lang M; Haag A; Baier A
    Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones inhibit HCV by targeting its helicase.
    Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
    Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
    Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
    Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.
    Lin K; Kwong AD; Lin C
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor.
    Manfroni G; Paeshuyse J; Massari S; Zanoli S; Gatto B; Maga G; Tabarrini O; Cecchetti V; Fravolini A; Neyts J
    J Med Chem; 2009 May; 52(10):3354-65. PubMed ID: 19388645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
    Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N
    Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
    Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
    Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
    Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
    Tani H; Fujita O; Furuta A; Matsuda Y; Miyata R; Akimitsu N; Tanaka J; Tsuneda S; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2010 Feb; 393(1):131-6. PubMed ID: 20117090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
    Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
    Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.